William P. Wiesmann, M.D.
President and Chief Executive Officer, Co-Founder

Dr. Wiesmann is the president and founder of a consulting company and several small biotech companies collectively called the BioSTAR Group. These companies focus on the development and commercialization of non-invasive sensors, automated diagnostic devices, and advanced tissue engineering hardware and applications. Dr. Wiesmann served as the Director for Combat Casualty Care at the U.S. Army Medical Research and Material Command Post at Ft. Detrick until he retired from the Army as a Colonel in 1997.

Dr. Wiesmann earned his undergraduate degree in chemistry from the University of Cincinnati and his medical degree from Washington University in St. Louis, Missouri. He completed advanced research training as a fellow at the National Heart, Blood and Lung Institute at the National Institutes of Health in Bethesda, MD. Dr. Wiesmann served as a senior scientist at the Walter Reed Institute of Research and as an attending nephrologist at Walter Reed Hospital in Washington DC.

His research interests include both clinical and laboratory biomedical research in cell biology and tissue engineering, immunology, trauma medicine, biomedical signal processing and biosensors. Dr. Wiesmann has been published in over 70 scientific publications, authored several book chapters and has a total of 20 patents awarded and pending. He serves on the Board of Trustees at Harvey Mudd College in Claremont, California, is the Chairman of the Scientific Advisory Board of the National Tissue Engineering Center (NTEC), is a member of the University of Southern California (USC) Engineering School Board of Councilors, and is a member of the University of Cincinnati Department of Biomedical Engineering External Advisory Board.



Keiki-Pua Dancil, Ph.D., M.BA.
Executive Vice President, Business Operations

As Executive Vice President of Business Operations, Dr. Dancil is responsible for business development, establishing new research activities and product development, overseeing product testing and marketing analysis, and strategic direction for corporate marketing.

Dr. Dancil has significant medical research and business development experience. Dr. Dancil previously held several positions at Trex Enterprises, including Director of Research and Development, and Program Manager for Trex Hawaii. During her tenure at Trex, Dr. Dancil was extensively involved in enhancing and sustaining their biosensor program. She has nine years of research and development experience in the fields of chemistry, biochemistry, material science, and biotechnology. Dr. Dancil received a Bachelor of Science degree in Chemistry from Santa Clara University, a Ph.D. in Chemistry / Biochemistry from University of California San Diego, and an MBA from Harvard Business School.

Dr. Dancil has been published in 11 scientific publications. She serves on the Scientific Advisory Council for Tissue Genesis Inc.



Marni Bienfang
Director of Development

As Director of Development, Ms. Bienfang is responsible for marketing, public relations and coordinating and managing HC research projects and external relations.

Ms. Bienfang has more than five years of business development and marketing experience including medical and aquaculture fields.

Ms. Bienfang earned a Bachelor degree in Business Administration, with an emphasis in International Business from Loyola Marymount University, Los Angeles, CA.

Ms. Bienfang is a member of the HSTC. She is proficient in Japanese and Chinese languages.



Shenda Baker, Ph.D.
Director of Pharmaceutical R&D

As Director of Pharmaceutical R&D, Dr. Baker is responsible for new product development and R&D of novel materials to prevent infection, promote wound repair, and facilitate drug delivery.

Dr. Baker has 15 years of experience conducting chemistry and biochemistry research, and has served as a college professor of chemistry for 13 years. Dr. Baker received tenure in 1999 in the Department of Chemistry at Harvey Mudd College and became a full professor in 2004.

Dr. Baker received Bachelor degrees in Chemistry and French from Grinnell College, and earned a Ph.D. in Physical Chemistry from the California Institute of Technology. She completed Postdoctoral Research at Los Alamos National Laboratory, Manuel Lujan Jr. Neutron Scattering Center.

She serves on the NSF Advisory Committee for GPRA Performance Assessment, is a member of the American Chemical Society, a member of the American Physical Society, a member of the Materials Research Society, a member of the Neutron Scattering Society of America, and a member of the Council for Undergraduate Research.

Her research interests include physical chemistry, polymer science, thin films, and nanoscopic structures and nanoscopic manipulation of biosensors and arrays; she has more than 40 publications reflecting this research.



Kenton Gregory, M.D.
Director of Chemical and Biochemical Processing, Co-Founder

Dr. Gregory is an associate professor of biomedical engineering at the Oregon Graduate Institute of Science and Technology and an assistant professor of medicine at Oregon Health and Science University. He also holds an endowed chair in laser medicine and surgery at the Providence St. Vincent Medical Center and serves as director at the Oregon Medical Laser Center (OMLC), which collaborates nationally in investigating such fields as hemorrhage control, laser thrombolysis for stroke, and elastin biomaterials for the repair and replacement of tissues.

Dr. Gregory received his undergraduate degree in engineering and Doctor of Medicine from the University of Southern California. He completed his internship, residency in Internal Medicine and a fellowship in Cardiology at the Wadsworth Veterans Administration Hospital in Los Angeles, California, and an additional research fellowship in Cardiology at the Irvine Medical Center in Orange County, CA. He has held teaching positions at the University of California, Irvine Medical School, Harvard University School of Medicine and served as staff cardiologist at Massachusetts General Hospital.

Dr. Gregory has been awarded 19 domestic patents, 3 international patents, has authored and/or co-authored 11 original reports, 4 book chapters, 36 manuscripts, and 80 abstracts. He has been Principal Investigator on 5 FDA sponsored clinical trials and received over $25 million in grants to research novel techniques for the repair and replacement of tissues. He is a member of numerous medical societies including the American Medical Society, American Heart Association, Society for Biomaterials and the American College of Cardiology, and he chairs a Cardiovascular Section at The International Society for Optical Engineering.